Instrument Inactif

Autres langues Oxeco PLC London S.E.

Actions

OXE

GB00B1J5QT30

Equipement et technologie médicale avancés

Cours en clôture London S.E.
- ^GBX	-

12/07	Tissue Regenix Group plc publie ses résultats pour l'exercice clos le 31 décembre 2025	CI
20/01	Tissue Regenix Group Ltd nomme Timothy James Sturm au poste d'administrateur, à compter du 13 janvier 2026	CI

Autres langues

12/07	Tissue Regenix Group plc Reports Earnings Results for the Full Year Ended December 31, 2025
20/01	Tissue Regenix Group Ltd Appoints Timothy James Sturm as Director, Effective January 13, 2026
20/01	Tissue Regenix Group plc Appoints Geoffrey Joseph Fitzhugh Gorman as Director, Effective January 13, 2026
14/01	Tissue Regenix Group plc Announces Termination of George Brian Phillips as Director, Effective January 9, 2026
14/01	Tissue Regenix Group Ltd Announces Termination of Directorship of Professor Shervanthi Homer Vanniasinkam Effective January 8, 2026
07/01	Galantas Gold buys Andacollo Oro gold project
07/01	Tissue Regenix Group Delists from London Bourse's AIM Segment
07/01	CellRight Technologies, LLC announced that it has received funding from Tissue Regenix Group plc, Harwood Capital LLP
08/12	Tissue Regenix's London Trading Halt to Continue Until Delisting in January 2026
08/12	Tissue Regenix does not believe it will be able to clarify co's financial position ahead of proposed cancellation date
04/12	Tissue Regenix Group plc announced that it expects to receive £17.5 million in funding
01/12	Tissue Regenix Gets Emergency Overdraft to Stay Solvent; Funding Needs Remain
01/12	Tissue Regenix secures $500k emergency overdraft
07/11	Tissue Regenix seeks to raise GBP5 million from shareholder
07/11	Tissue Regenix Flags Funding Needs to Remain Operational
22/10/25	Genflow patent progress; Accsys new debt facilities
17/10/25	Tissue Regenix Appoints Kirsten Lund to Board, Effective October 16, 2025
16/10/25	Tissue Regenix announces losses in restatement, reshuffles board
16/10/25	Tissue Regenix CEO Steps Down; Executive Chair Becomes Acting CEO
16/10/25	Tissue Regenix CEO Daniel Lee leaves, Jay LeCoque becomes acting CEO
16/10/25	Tissue Regenix Group plc Announces Board Changes, Effective 16 October 2025
16/10/25	Tissue Regenix Group plc Announces CEO Changes, Effective 16 October 2025
30/09/25	EARNINGS: GENinCode sees annual revenue growth slower than expected
30/09/25	FTSE 100 higher despite US shutdown fears
30/09/25	AIM WINNERS & LOSERS: Verici Dx rises; Billington profit plunges